Financial Ratios

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE951.50-20.5 (-2.11 %)
PREV CLOSE ( ) 972.00
OPEN PRICE ( ) 987.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14663
TODAY'S LOW / HIGH ( )945.00 987.95
52 WK LOW / HIGH ( )540.1 1107.85
NSE952.05-21.45 (-2.2 %)
PREV CLOSE( ) 973.50
OPEN PRICE ( ) 975.40
BID PRICE (QTY) 952.05 (18)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 495457
TODAY'S LOW / HIGH( ) 945.00 979.00
52 WK LOW / HIGH ( )547 1108.35
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)34.917.6216.9626.0736.55
   CEPS(Rs)43.1815.2123.2731.4640.94
   DPS(Rs)5.504.505.256.756.25
   Book NAV/Share(Rs)257.64229.51223.21211.31193.55
   Tax Rate(%)17.3310.7821.0918.6221.28
Margin Ratios
   Core EBITDA Margin(%)34.2311.5624.6430.6137.52
   EBIT Margin(%)32.509.1823.9431.9739.80
   Pre Tax Margin(%)32.148.4623.2730.8838.94
   PAT Margin (%)26.577.5518.3625.1330.65
   Cash Profit Margin (%)32.8715.0625.2030.3234.33
Performance Ratios
   ROA(%)12.292.866.5910.5416.49
   ROE(%)14.333.377.8212.8620.11
   ROCE(%)16.513.799.4614.8523.91
   Asset Turnover(x)0.460.380.360.420.54
   Sales/Fixed Asset(x)0.780.650.700.991.41
   Working Capital/Sales(x)1.251.221.021.201.40
Efficiency Ratios
   Fixed Capital/Sales(x)1.281.531.431.010.71
   Receivable days104.1896.61101.4199.3892.04
   Inventory Days100.00145.29140.0799.8178.34
   Payable days121.62102.03144.40215.17256.97
Valuation Parameters
   PER(x)16.1599.3648.6619.4115.64
   PCE(x)13.0549.8035.4616.0913.96
   Price/Book(x)2.193.303.702.402.95
   Yield(%)0.980.590.641.331.09
   EV/Net Sales(x)4.277.989.105.295.31
   EV/Core EBITDA(x)10.7945.8729.0213.5011.15
   EV/EBIT(x)12.8883.3937.3015.6912.18
   EV/CE(x)1.862.833.172.042.42
   M Cap / Sales4.387.829.115.155.25
Growth Ratio
   Net Sales Growth(%)32.996.91-7.64-9.87-5.02
   Core EBITDA Growth(%)202.41-40.70-26.09-25.84-2.22
   EBIT Growth(%)360.58-58.07-33.16-30.30-4.00
   PAT Growth(%)358.02-55.06-34.77-28.87-4.45
   EPS Growth(%)358.02-55.06-34.95-28.68-3.41
Financial Stability Ratios
   Total Debt/Equity(x)0.030.090.060.080.11
   Current Ratio(x)4.383.334.183.403.19
   Quick Ratio(x)3.362.322.792.652.48
   Interest Cover(x)90.6212.7235.7129.3146.07
   Total Debt/Mcap(x)0.020.030.020.030.04

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.